Viewing StudyNCT00424255

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00424255
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2007-01-17
Brief Title: Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Neoplasms Head and Neck
Keywords:
Name View
Head cancer View
Cancer of the Head and Neck View
Neck cancer View
Adjuvant View
Head and neck cancer View
High-risk head and neck cancer View
Post-surgery View